Auswirkungen des GKV-Finanzstabilisierungsgesetzes auf die Arzneimittelversorgung

This is a written parliamentary inquiry regarding how the Statutory Health Insurance Financial Stabilization Act affects the availability of pharmaceuticals. It seeks to determine if the financial measures intended to stabilize health insurance funds are creating shortages or restricting access to essential medicines. The procedure primarily affects patients relying on prescription medications and pharmaceutical providers. It examines whether budget-cutting measures in the healthcare system are negatively impacting the drug supply chain.